The software updates could cause alarms to stop working and cause the battery to drain without warning and potentially interrupt therapy, which could lead to serious injury or death.
Smiths Medical ASD, Inc. Recalls Medfusion® 4000 Syringe Pumps Due to Malfunctioning Alarms and Potential Interruption of Therapy
More from FDA News AlertsMore posts in FDA News Alerts »
- FDA In Brief: FDA Makes Progress on Efforts to Understand Presence of Asbestos in Cosmetic Products
- Coronavirus (COVID-19) Update: October 22, 2021
- Federal Judge Enters Consent Decree with Utah-based Dietary Supplement Manufacturer
- Coronavirus (COVID-19) Update: FDA Takes Additional Actions on the Use of a Booster Dose for COVID-19 Vaccines
- FDA In Brief: FDA Announces Investigation of Salmonella Outbreak Linked to Whole, Fresh Onions